Skip to main content

Peer Review reports

From: Effectiveness and safety of different doses of febuxostat compared with allopurinol in the treatment of hyperuricemia: a meta-analysis of randomized controlled trials

Original Submission
19 Mar 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
4 May 2023 Reviewed Reviewer Report
16 May 2023 Reviewed Reviewer Report
26 May 2023 Author responded Author comments - Deng-Chao Wang
Resubmission - Version 3
26 May 2023 Submitted Manuscript version 3
26 May 2023 Author responded Author comments - Deng-Chao Wang
Resubmission - Version 4
26 May 2023 Submitted Manuscript version 4
29 May 2023 Author responded Author comments - Deng-Chao Wang
Resubmission - Version 5
29 May 2023 Submitted Manuscript version 5
30 May 2023 Author responded Author comments - Deng-Chao Wang
Resubmission - Version 6
30 May 2023 Submitted Manuscript version 6
6 Sep 2023 Reviewed Reviewer Report
27 Nov 2023 Reviewed Reviewer Report
29 Nov 2023 Author responded Author comments - Deng-Chao Wang
Resubmission - Version 7
29 Nov 2023 Submitted Manuscript version 7
Publishing
11 Dec 2023 Editorially accepted
14 Dec 2023 Article published 10.1186/s40360-023-00723-5

You can find further information about peer review here.

Back to article page